GeoVax Labs, Inc.
- Last sale
- Nov 12, 2026 · -15.34%
- Market cap
- $1.10M
- 544.45K shares
- Filings
- 1,028
Q3 2026−37.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
FY 2021N/M FY21 yoy
Q3 2026−44.0% FY25 yoy
- $1.10M
- —
- —
- 1.0×
- -1503.85%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,489,145 | reported | |
| FY 2024 | 2024-12-31 | $3,954,576 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $81,526 | reported | |
| FY 2021 | 2021-12-31 | $385,501 | reported | |
| FY 2020 | 2020-12-31 | $1,823,658 | reported | |
| FY 2019 | 2019-12-31 | $1,175,896 | reported | |
| FY 2018 | 2018-12-31 | $963,203 | reported | |
| FY 2017 | 2017-12-31 | $1,075,270 | reported | |
| FY 2016 | 2016-12-31 | $828,918 | reported |
Segments
Products
LineFY2022ShareChange
NIH Grants$81.53K100%−78.9%
Research Agreements———
Total$81.53K
Pharmaceutical preparations
GeoVax Labs, Inc. is the 199th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
TXMDTherapeuticsMD, Inc.$3.0M71.6%18.8%$20.9MXBIOXenetic Biosciences, Inc.$3.0M19.0%90.1%$4.3MUPBUpstream Bio, Inc.$2.9M20.4%5,026.0%$156.5MRNACCartesian Therapeutics, Inc.$2.8M92.8%4,658.6%$194.3MTRAWTraws Pharma, Inc.$2.8M1,134.5%328.7%$4.2M
GOVXGeoVax Labs, Inc. (this company)$2.5M37.1%862.3%$1.1M
KRSAKorsana Biosciences, Inc.$2.1M3.7%170.1%$1.4BDNTHDianthus Therapeutics, Inc.$2.0M67.3%7,973.3%$5.2BORMPOramed Pharmaceuticals Inc.$2.0M—3,202.5%$175.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
GeoVax Labs, Inc. · CIK 832489 · Engraved from SEC EDGAR